The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Apr 2021 12:56

RNS Number : 5209U
Circassia Group Plc
06 April 2021
 

Circassia Group plc

Director/PDMR Shareholding

Oxford, UK - 6 April 2021: Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on respiratory diagnostics and monitoring, today announces that on 1 April 2021, Ian Johnson, Executive Chairman, purchased 100,000 Ordinary Shares at a price of 28.50 pence per share, Michael Roller, Chief Financial Officer purchased 175,000 Ordinary Shares at a price of 28.91 pence per share and Jonathan Emms, Chief Operating Officer, purchased 67,928 Ordinary Shares at a price of 29.42 pence per share. In addition to this, on 6 April 2021, Ian Johnson purchased 100,000 Ordinary Shares at a price of 29.25 pence per share.

Following these purchases, Ian Johnson holds 400,000 Ordinary Shares (0.10% of the issued share capital of the Company), Michael Roller holds 375,000 Ordinary Shares (0.09% of the issued share capital of the Company) and Jonathan Emms holds 667,928 Ordinary Shares (0.16% of the issued share capital of the Company).

Additional detail is provided below in accordance with the requirements of UK MAR.

Contacts

Circassia

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

Sarah Duncan, Company Secretary

 

Tel: +44(0)1865 405566

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Jen Boorer / Hannah Woodley

Tel: +44 (0) 20 7496 3000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

(1) Ian Johnson

(2) Michael Roller

(3) Jonathan Emms

2.

Reason for the notification

a.

Position/status

(1) Executive Chairman

(2) Chief Financial Officer

(3) Chief Operating Officer

b.

Initial notification/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Group plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

(1a) 28.50p

(1b)* 29.25p

(2a) 28.00p

(2b) 28.92p

(3) 29.42p

(1a) 100,000

(1b)* 100,000

(2a) 2,500

(2b) 172,500

(3) 67,928

d.

Aggregated information

· Aggregated volume

· Price

 

 

Price(s)

Volume(s)

(1) 28.88p

(2) 28.91p

(3) 29.42p

(1) 200,000

(2) 175,000

(3) 67,928

e.

Date of the transaction

01/04/2021

*06/04/2021

f.

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFQLFBFZLEBBE
Date   Source Headline
27th Jan 202011:47 amRNSHolding(s) in Company
21st Jan 20201:46 pmRNSHolding(s) in Company
17th Jan 20203:34 pmRNSHolding(s) in Company
15th Jan 20202:22 pmRNSHolding(s) in Company
13th Jan 20203:13 pmRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
9th Jan 20204:26 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSCircassia Announces Business Update
3rd Jan 202011:53 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
19th Dec 20192:03 pmRNSGrant of Options
19th Dec 20197:04 amRNSUpdate on Licensing Agreement with BeyondAir Inc.
17th Dec 201910:50 amRNSHolding(s) in Company
13th Dec 20194:05 pmRNSHolding(s) in Company
6th Dec 201912:25 pmRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSCircassia Announces Board Changes
3rd Dec 20194:33 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights Update
27th Nov 20191:38 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSHolding(s) in Company
26th Nov 20194:55 pmRNSHolding(s) in Company
26th Nov 20194:51 pmRNSHolding(s) in Company
25th Nov 20195:38 pmRNSHolding(s) in Company
25th Nov 20195:35 pmRNSHolding(s) in Company
4th Nov 20192:48 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights Update
21st Oct 20197:00 amRNSUS launch of Duaklir at CHEST 2019
17th Oct 20195:34 pmRNSGrant of options
4th Oct 20194:30 pmRNSHolding(s) in Company
1st Oct 201911:25 amRNSDirector/PDMR Shareholding
30th Sep 201911:06 amRNSTotal Voting Rights
30th Sep 201911:02 amRNSBlock listing Interim Review
26th Sep 20197:00 amRNSInterim Results for Six Months Ended 30 June 2019
20th Sep 20193:37 pmRNSHolding(s) in Company
19th Sep 20195:40 pmRNSHolding(s) in Company
18th Sep 20195:26 pmRNSHolding(s) in Company
18th Sep 20195:21 pmRNSHolding(s) in Company
17th Sep 20191:10 pmRNSHolding(s) in Company
17th Sep 201912:01 pmRNSHolding(s) in Company
16th Sep 20194:51 pmRNSHolding(s) in Company
13th Sep 20195:57 pmRNSBlock listing Interim Review
12th Sep 20197:00 amRNSNotice of Results and Appointment of Joint Broker
30th Aug 20197:00 amRNSTotal Voting Rights
23rd Aug 20195:23 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAppointment of Jonathan Emms as COO
31st Jul 20191:55 pmRNSTotal Voting Rights
22nd Jul 20194:12 pmRNSHolding(s) in Company
9th Jul 20191:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.